ECRI included other medtech-related threats on its list of patient safety concerns, noting that cybersecurity breaches can ...

Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 millionTransaction expected to close by ...

The Minnesota Attorney General's Office investigation into Mayo Clinic found that it deterred some patients from applying for ...

The fight over whether terminated pregnancy reports (TPRs) filed with the state are public records took a new turn Wednesday ...

In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

A paediatric specialist told the Sessions Court here today that Zayn Rayyan Abdul Matin could only speak using 30 words and ...

Evoke Pharma, Inc. ( NASDAQ: EVOK) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Daniel Kontoh-Boateng – DKB Partners Matt D’Onofrio – Chief Executive Officer Chris Quesenberry – Chief ...

Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...